Promentis Pharmaceuticals, Inc.

Promentis Pharmaceuticals, Inc.

Promentis Pharmaceuticals, Inc.

Overview
Date Founded

2007

Headquarters

826 North Plankinton Avenue,Suite 400,Milwaukee, WI 53203

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Medical Support Services
Biotechnology
Holding Companies

Company Description

Promentis Pharmaceuticals, Inc. operates as a pharmaceutical company that develops novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded in 2007 by David A. Baker and John Mantsch and is headquartered in Milwaukee, WI.

Executives & Employees

Co-Founder

Chairman & Chief Executive Officer

President

Chief Medical Officer

Senior Director & Head of Clinical Operations

Director of Research

Senior Vice President-Research & Development

Vice President of Finance

Board of Directors

Venture Partner at OrbiMed Advisors LLC

Venture Partner at OrbiMed Advisors LLC

Executive Partner at F-Prime Capital Partners

Partner at Aisling Capital

President at Promentis Pharmaceuticals, Inc.

Managing Director at Black Horse Investments GmbH

Paths to Promentis Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Promentis Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Promentis Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Promentis Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Promentis Pharmaceuticals, Inc. raised money in a private placement transaction

Advisors & Consultants
Publicist

Senior Account Executive at Tiberend Strategic Advisors, Inc.

Publicist

Vice President at Tiberend Strategic Advisors, Inc.

Investors
Details Hidden

Black Horse Investments GmbH provides investment services. The firm's investment operations focus on pharmaceutical businesses and property development activities. Its focus areas encompass asset management, project management, and business development and financing. The company is headquartered in Duesseldorf, Germany.

Details Hidden

Golden Angels Investors LLC operates as an investment company that engages in helping capital formation for entrepreneurs in the Midwest. The firm invests in early stage businesses and helping these businesses accelerate in the market. The company was founded by Timothy Keane in 2002 and is headquartered in Brookfield, WI.

Details Hidden

OrbiMed focuses exclusively on global investments across the entire spectrum of private and publicly-traded life sciences companies. They seek to invest in the most promising investment opportunities regardless of a company's stage of development. The firm invests at all stages of development from private start-ups and university spinouts to the largest global pharmaceutical companies. OrbiMed focuses on companies involved in drug development, drug discovery and medical devices, with particular emphasis on mid-stage private companies. Investments typically range from $5 million to $40 million. OrbiMed is generally a lead investor and takes an active role on their portfolio companies' boards of directors